Acute Porphyria Drug Database

C07AA07 - Sotalol
Not porphyrinogenic
NP

Rationale
Beta-blocker, not metabolised. Occasional clinical observation of tolerance. Two references state non-porphyrinogenicity.
Chemical description
Watersoluble beta-receptor blocking substance. Excreted unchanged in urine. Thunell, patient reports (n=3 ): tolerated. South African list: use. French list: authorized. EPI: safe (betablockers)
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes C07A / C07AA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙